| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 77 |
| 1 | METHOTREXATE SODIUM | 77 |
| 2 | METHOTREXATE | 75 |
| 3 | PREDNISONE | 74 |
| 4 | RITUXIMAB | 54 |
| 5 | ETANERCEPT | 53 |
| 6 | INFLIXIMAB | 53 |
| 7 | MYCOPHENOLATE MOFETIL | 45 |
| 8 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 45 |
| 9 | BORTEZOMIB | 40 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MIGLUSTAT | 4 | 0.0034 |
| 1 | BUSULFAN | 33 | 0.0021 |
| 2 | NITROUS OXIDE | 4 | 0.0018 |
| 3 | DACARBAZINE | 11 | 0.0015 |
| 4 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 4 | 0.0014 |
| 5 | VINORELBINE | 10 | 0.0014 |
| 6 | ASCIMINIB | 5 | 0.0014 |
| 7 | DASATINIB | 13 | 0.0014 |
| 8 | BINIMETINIB | 11 | 0.0014 |
| 9 | GOLIMUMAB | 17 | 0.0013 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lead Chelator [EPC] | 1 | 0.0119 |
| 1 | Enzyme Stabilizer [EPC] | 4 | 0.0034 |
| 2 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 3 | Glucosylceramide Synthase Inhibitor [EPC] | 4 | 0.0014 |
| 4 | CD30-directed Immunoconjugate [EPC] | 11 | 0.0011 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 6 | 0.0010 |
| 6 | CD22-directed Immunoconjugate [EPC] | 3 | 0.0010 |
| 7 | Human Immunoglobulin G [EPC] | 16 | 0.0008 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 69 | 0.0007 |
| 9 | CTLA-4-directed Blocking Antibody [EPC] | 29 | 0.0006 |